Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Voriconazole manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Italy

Clear all

1 products found

voriconazole

Powder for solution for infusion 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , United Arab Emirates , Egypt , China , Chile , Algeria , United States , Cambodia , Canada
Registered in
United Kingdom , Denmark , Italy
Manufacturer #17548
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in Europe, North America, and Asia for 100+ years. Main therapeutic areas include gastroenterology, anti-infectious drugs, inflammation and pain, and nutraceuticals. The main dosage forms are injectable, oral, and topical. They are produced in cGMP-compliant manufacture.

Manufacturer usually replies in 10 days

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Voriconazole belongs to a class of drugs known as azole antifungals. Voriconazole is a broad spectrum, triazole antifungal agent and is indicated in adults and children aged 2 years and above. This medication is used to treat serious fungal infections caused by Scedosporium apiospermum and Fusarium spp. It is also used to treat invasive fungal infections that are generally seen in patients who are immunocompromised. These include invasive candidiasis, invasive aspergillosis, and emerging fungal infections. Voriconazole is advised as a prescription product as well as generic prescription product. Manufacturers market Voriconazole under the Brand name of Vfend. Voriconazole is available in the dosage form of Tablet (Film Coated), Powder (for Suspension and for Solution) and I.V. Injections. Tablet and Powder for Suspension are taken orally, whereas Powder for Solution and Injections are administered intravenously. Voriconazole Tablet are available in dosage strength of 50 mg and 200 mg, and Powder for Suspension is available in 40 mg/1mL and 200 mg. The Voriconazole injections are available in 10 mg/1mL dosage strength. These injections are available as a single dose unpreserved sterile lyophile, which are for single use only and any unused solution should be discarded. Only clear solutions without particles should be used. The Voriconazole tablet and Oral suspension must be taken at least one hour before or after meal, usually every 12 hours. Voriconazole I.V. injection requires reconstitution to 10 mg/mL and subsequent dilution to 5 mg/mL or less prior to administration as an infusion, at a maximum rate of 3 mg/kg per hour over 1 to 2 hours. The diluted I.V. must be administered by intravenous infusion over 1 to 2 hours only and it should not be administered as an IV bolus injection. Voriconazole Tablets should be stored at 15° C to 30° C (59° F - 86° F). Before reconstitution, Powder for Oral Suspension should be stored at 2° C to 8° C (36° F - 46° F) (in a refrigerator). The reconstituted suspension should be stored at 15° C to 30° C (59° F - 86° F). It should not be refrigerated or freeze and the container must be tightly closed. Wholesale Price of Voriconazole The wholesale price of Voriconazole 50 mg oral tablet costs around $ 162.91 for 30 tablets and the lowest available price is $ 1.51 per tablet for 84 tablets (Bottle) at local U.S pharmacies. The per unit cost 200 mg voriconazole oral tablet is around $ 8.02 - $ 37.83 which costs around $ 240.61 for 30 tablets. The per unit price of 200 mg voriconazole intravenous powder for injection is $ 44.23 Voriconazole - Mechanism of Action The primary mode of action of Voriconazole is the inhibition of fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis. Voriconazole binds and inhibits ergosterol synthesis by inhibiting CYP450-dependent 14-alpha sterol demethylase. The inhibition of 14-alpha sterol demethylase results in depletion of ergosterol in fungal cell membrane and thus responsible for the antifungal activity of Voriconazole. Finding Voriconazole Manufacturers and Suppliers Finding an accurate partner in our business is one of the big challenges and to overcome that challenges and to make one’s work easy in finding the accurate and good manufacturer and supplier of Voriconazole one can visit the Pipelinepharma website which helps one in finding the dependable manufacturers and suppliers of Voriconazole. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products, quickly connects owner with the buyer for the business advancement. One can filter the product names in unified search engine by its country, category, therapeutic area, forms, dossier and its status, regulatory filings, approvals, and more.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation